https://www.taxtmi.com/news?id=47579 Illumina agreed to acquire SomaLogic and specified assets for cash at closing plus contingent performance based milestones and royalties, subject to customary closing conditions. The deal integrates SomaLogic's aptamer based proteomics platform, certified Boulder facilities, and kitted NGS panels into Illumina's NGS, software, and multiomics ecosystem to accelerate proteomics development, create a consumables revenue stream, and pursue projected non GAAP profitability and margin alignment. Completion requires regulatory approvals and customary clearances, with an anticipated closing timeline in the first half of 2026. en-us Wed, 25 Jun 2025 17:31:03 +0530 Wed, 25 Jun 2025 17:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=47579 Illumina agreed to acquire SomaLogic and specified assets for cash at closing plus contingent performance based milestones and royalties, subject to customary closing conditions. The deal integrates SomaLogic's aptamer based proteomics platform, certified Boulder facilities, and kitted NGS panels into Illumina's NGS, software, and multiomics ecosystem to accelerate proteomics development, create a consumables revenue stream, and pursue projected non GAAP profitability and margin alignment. Completion requires regulatory approvals and customary clearances, with an anticipated closing timeline in the first half of 2026. News - Wed, 25 Jun 2025 17:31:03 +0530 https://www.taxtmi.com/news?id=47579